Conclusion:
In summary, as a study that isolated first SARS-CoV-2 strain and identified a bat coronavirus
with high homology to SARS-CoV-2, it is critical that all data relating to viral genomes are of top
quality, since many studies used or might use them as reference sequences. Meanwhile,
although the leadership in Wuhan Institute of Virology might highlight their impressive speed to
complete all related experiments described in the paper16, the accurate patient sample
collection date and sequencing data with better quality needs to be recorded in the scientific
paper.
In addition, there have been no studies on RaTG13’s infectivity in bat/human cells or in animal
models, its interactions with antibodies or antiviral drugs. There is lack of understandings on
RaTG13’s virulence, transmissibility, pathogenicity, immune epitopes, immune evasion
mechanism, etc. This was because WIV did not isolate the RaTG13 virus and does not have any
related viral stocks, if the statement from Dr. Yanyi Wang (the director of WIV) in a recent TV
interview17 was accurate.
Therefore, a careful examination of the related RaTG13 samples and raw data sets of its
genome sequencing are warranted to exclude any possibilities of errors or the potential coinfection
of two different strains of coronavirus. And the authors need to clearly explain the
relationship between RaTG13 and BtCoV/4991, whether they were the same strain or two
closely related strains.
This paper was rushed to make a premature connection between bat coronavirus and SARSCoV-
2, drawing a potential bat origin scenario to support SARS-CoV-2 zoonotic transmission
from bat to human. However, this connection was based on a potential bat coronavirus strain
RaTG13, that may not truly exist, considering its key information missing: such as no related bat
sample description, no sequencing procedure details published, confusion/identity issue with
BtCoV/4991 strain, unusual sequence features, no viral isolation and related characterization,
et al.
In light of these concerns, we call for the retraction of this Nature paper1 to further verify the
sequencing data, patient sample collection date and provide more information regarding the
origin, identification and characterization of this BatCoV RaTG13. Proper verification should
involve Dr. Zhengli Shi sending the RaTG13 and BtCoV/4991-related bat samples to other noncollaborating
laboratories to be analyzed independently. And this Nature paper1 should be
cautious on making the “probable bat origin” hypothesis before RaTG13 existence could be
confirmed.